Early Free Light‐Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA‐Directed CAR‐T Cells
Guido Kobbe, Christof Scheid, Udo Holtick, Tobias A.W. Holderried, Daniel Schuette, Nathan Wolfensberger, Hishan Tharmaseelan, Philipp Gödel, Michael J. Hallek, Martina Crysandt, Friederike Schmitz, Tim Richardson, Ben‐Niklas Baermann
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
eJHaemVol. 6(5)
Institutions
University of Cologne (DE), University Hospital Bonn (DE), Universitätsklinikum Aachen (DE), University Hospital Cologne (DE), Heinrich Heine University Düsseldorf (DE)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Early Free Light‐Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA‐Directed CAR‐T Cells — Guido Kobbe, Christof Scheid, et al. · eJHaem (2025) | TGRS Research Map | TGRS